Building a better world for everyone. Since it was established by Trinity College in 1970, the Cambridge Science Park has played a pivotal role in the “Cambridge Phenomenon” - the transformation of Cambridge from a market town with a world-class university to one of the hottest technology hotspots in the world. Today the 152-acre site is home to 100 science and technology companies ranging from spin-outs from the University of Cambridge to multinational companies seeking access to the brightest graduates and entrepreneurs from Cambridge’s diverse talent pool. Many are working on potentially life changing technologies from personalised medicines and non-invasive …

Sectors: Real Estate Startup accelerator & VC

The most founder-focused event on Earth. Slush 2024 is on Nov 20–21. Tickets out now: slush.org/tickets The most founder-focused event on Earth is taking place on Nov 20–21 in Helsinki, Finland. Welcome to Slush 2024: Metamorphosis. Tickets out now: slush.org/tickets Slush is a not-for-profit on a mission to help and create founders to change the world. Founded in 2008, Slush annually hosts the world's leading startup event in Helsinki, Finland. Slush is run by students and recent graduates. International, High-growth, Startups, and Investors

Transforming learning solutions in the education sector! #xEdu #WeArexEdu #Accelerating #Education 📌 xEdu is the leading EdTech accelerator that works with startups creating transformative learning solutions in the Education sector. From product development to market entry, xEdu offers assistance in various areas including coaching, mentoring, real-life environment for testing, research and marketing. Our community of experts are here to help you reach the next level, with decades of experience in technology, education and business. 📍 🇫🇮 Based in Finland, a country renowned for its exceptional educational system and pioneering tech and gaming industries, xEdu combines these strengths with a dynamic …

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please …

Sectors: Pharmaceutical